Ligand to Report Second Quarter 2018 Results on August 6th

Go back to Ligand to Report Second Quarter 2018 Results on August 6th
LIGAND PHARMA (NASDAQ: LGND) Delayed: 289.01 +1.62 (0.56%)
Previous Close $287.39    52 Week High $139.79 
Open $288.09    52 Week Low $82.07 
Day High $289.98    P/E 672.12 
Day Low $285.87    EPS $0.43 
Volume 58,855